423 filings
8-K
OCGN
Ocugen Inc
28 Dec 20
Submission of Matters to a Vote of Security Holders
5:02pm
DEFR14A
OCGN
Ocugen Inc
23 Dec 20
Revised proxy
5:30pm
DEFA14A
OCGN
Ocugen Inc
22 Dec 20
Additional proxy soliciting materials
9:54pm
8-K
OCGN
Ocugen Inc
22 Dec 20
Ocugen and Bharat Biotech TO Co-DEVELOP COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US market
9:08am
DEFA14A
OCGN
Ocugen Inc
11 Dec 20
Additional proxy soliciting materials
12:00am
DEFA14A
9s88o3e
2 Dec 20
Additional proxy soliciting materials
12:00am
8-K
e9zshnu2y3zqxabov1
6 Nov 20
Regulation FD Disclosure
8:05am
8-K
y93v61it p1kn
6 Nov 20
Ocugen Provides Business Update and Third Quarter 2020 Financial Results
7:41am
8-K
1i394su hpy
20 Oct 20
Results of Operations and Financial Condition
9:16am
8-K
x1f sapcohh77
6 Oct 20
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
8:50am
8-K
8s9mhgjb
8 Sep 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
7uj4hl4qe925 8yray1d
31 Aug 20
Other Events
4:11pm
4
g4i6zd4qm5ddisb
17 Aug 20
Ocugen / Vijay Tammara ownership change
7:55pm
8-K
cuxbwxth
17 Aug 20
Regulation FD Disclosure
9:16am
424B5
fxd dgbgm44bma
14 Aug 20
Prospectus supplement for primary offering
9:28pm
8-K
k5ubeuxm4v92si2
14 Aug 20
Entry into a Material Definitive Agreement
9:07pm
8-K
3mj6vuiewe8p
14 Aug 20
Ocugen Provides Business Update and Second Quarter 2020 Financial Results
7:39am